Delivery Order SPE2DB24D2205-SPE2DB25FEFBP
Award Date 7/18/25
Potential Completion Date 8/8/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $90,838.24 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tezspire 210 mg/1.91 ml syringes. The contract has an ultimate completion date of March 30, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support...
- The Defense Logistics Agency awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp on July 21, 2025, for TEZSPIRE 210 mg/1.91 mL pen auto-injectors. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 11, 2025. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Tezspire 210 mg/1.91 mL pen auto-injectors valued at $4,687.18, with completion scheduled for August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The contract is to be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,343.59 on July 21, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by August 11, 2025, with performance taking place at the company's Conshohocken facility. The contract was funded by the Defense Logistics Agency's Medical Supply Chain division to...
- The Defense Logistics Agency awarded a $2,343.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 MG/1.91 ML pen injectables, with performance through August 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $9,374.36 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pens on July 25, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order is unset-aside and competitively awarded, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Tezspire is a monoclonal antibody biologic used in asthma and chronic rhinosinusitis treatment, representing part of...
- The Defense Logistics Agency awarded a $14,061.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors, with an ultimate completion date of August 8, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- This is a $23,435.90 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML syringes, with a performance period ending on July 23, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,530.60 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a period of performance through October 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical commodities, including prescription medications,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,795.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML pharmaceutical products. This delivery order is under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to supply pharmaceuticals and...